Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-30

FDA Approved: NEBIVOLOL — Original Application (Apnar Pharma LP)

View source ↗

Summary

The FDA approved nebivolol hydrochloride as a generic drug under an original ANDA filed by Apnar Pharma LP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol hydrochloride (Nebivolol hydrochloride)

Snippet

ORIG AP for NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)